800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema (ELEVAATE OLE)

view all Clinical Trials

Overview

This is a Phase 2, Single Arm, Open Label Extension Study, Evaluating the Long-Term Safety and Clinical Efficacy of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency (AATD) Emphysema.

Clinical Trial Information

Protocol

TIRB#: 31882

Phase

2

Condition(s)

Chronic Obstructive Pulmonary Disease (COPD), Alpha-1 Antitrypsin Deficiency, Emphysema

Investigator

Wissam Chatila, MD, PhD

Coordinator

Sara Khademolhosseini

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Phase 2, Single Arm, Open Label Extension Study, Evaluating the Long-Term Safety and Clinical Efficacy of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency (AATD) Emphysema